Markets
Tech
Media
Success
Video
Markets
Premarkets
Dow
After-Hours
Market Movers
Fear & Greed
World Markets
Investing
Markets Now
Before the Bell
Leading Indicator
Global Energy Challenge
Economy
Tracking America's Recovery
Energy
Tech
Innovate
Gadget
Mission: Ahead
Upstarts
Business Evolved
Work Transformed
Innovative Cities
Unhackable
Media
Reliable Sources
Success
Boss Files
Fresh Money
Cars
Homes
Biz + Leisure
Center Piece
Perspectives
Video
International
Switzerland
India
Davos
Passion to Portfolio
On: Germany
More
Newsletters
About Us
Accessibility and CC
U.S.
World
Politics
Business
Opinion
Health
Entertainment
Tech
Style
Travel
Sports
Video
Shop
VR
More...
Follow CNN Business
Do Not Sell
Moderna Inc
(NASDAQ:MRNA)
160.14
Delayed Data
As of
5:28pm ET
+10.43
/
+6.97%
Today’s Change
33.15
Today
|||
52-Week Range
189.26
+53.29%
Year-to-Date
Quote
Profile
News
Charts
Forecasts
Financials
Shareholders
Competitors
Latest MRNA News
|
Press Releases
Why Moderna Stock Popped Today
8:11pm / MotleyFool.com - Paid Partner Content
Dow slips, but S&P 500 notches record, as US urges pause on J&J vaccine
Apr 13 / CNN.com - Paid Partner Content
JNJ Vaccine Pause Gives Stay-at-Home ETFs a Shot in the Arm
11:10am / Zacks.com - Paid Partner Content
Bristol Myers' (BMY) Opdivo Combo Encouraging in NSCLC study
Apr 12 / Zacks.com - Paid Partner Content
Geron (GERN) Begins Phase III Myelofibrosis Study on Imetelstat
9:40am / Zacks.com - Paid Partner Content
APEIRON CAPITAL Ltd Buys Moderna Inc, Sells Pinduoduo Inc
Apr 12 / GuruFocus News - Paid Partner Content
Stock Market News for Apr 14, 2021
8:59am / Zacks.com - Paid Partner Content
Has Moderna (MRNA) Outpaced Other Medical Stocks This Year?
Apr 12 / Zacks.com - Paid Partner Content
US Technology Stocks Close With Leading Gains Tuesday
8:58am / GuruFocus News - Paid Partner Content
Stock Market News for Apr 12, 2021
Apr 12 / Zacks.com - Paid Partner Content
Which Vaccine Maker Will Win the Fight Against COVID-19?
8:17am / Zacks.com - Paid Partner Content
J&J's (JNJ) COVID-19 Jab Under EU Review for Rare Blood Clots
Apr 12 / Zacks.com - Paid Partner Content
J&J (JNJ) COVID-19 Jab to be Paused on FDA/CDC Recommendation
6:50am / Zacks.com - Paid Partner Content
Moderna Inc (MRNA) CEO Stephane Bancel Sold $2.5 million of Shares
Apr 12 / GuruFocus News - Paid Partner Content
You Can Make $250 Every Month From Investing in These 3 Stocks
6:40am / MotleyFool.com - Paid Partner Content
3 Stocks That Could Suffer if Biden Gives In to This Pressure
Apr 10 / MotleyFool.com - Paid Partner Content
Could Johnson & Johnson Be a Big Winner in the Flu Vaccine Market?
6:09am / MotleyFool.com - Paid Partner Content
3 Biotech Stocks With Big Catalysts Around the Corner
Apr 10 / MotleyFool.com - Paid Partner Content
Here's the Surprising Amount of Money Pfizer's Vaccine Might Make Immunizing Adolescents
5:52am / MotleyFool.com - Paid Partner Content
Bristol Myers' (BMY) Opdivo Combo Positive in ESCC Study
Apr 09 / Zacks.com - Paid Partner Content
Johnson & Johnson's COVID Vaccine Paused: 5 Answers to Your Questions
5:52am / MotleyFool.com - Paid Partner Content
ImmunityBio (IBRX) Reports Positive COVID-19 Vaccine Data
Apr 09 / Zacks.com - Paid Partner Content
How Johnson & Johnson's vaccine pause could slow the economic recovery
4:15am / CNN.com - Paid Partner Content
Why Moderna Stock Is Jumping Today
Apr 09 / MotleyFool.com - Paid Partner Content
Why Moderna Stock Surged Today
Apr 13 / MotleyFool.com - Paid Partner Content
Merck (MRK) Keytruda Meets Endpoint in Kidney Cancer Study
Apr 09 / Zacks.com - Paid Partner Content
S&P 500 Hits Another New All-Time High
Apr 13 / Zacks.com - Paid Partner Content
Higher-Than-Expected PPI in March
Apr 09 / Zacks.com - Paid Partner Content
Osher Van de Voorde Investment Management Buys Moderna Inc, Sells Facebook Inc
Apr 13 / GuruFocus News - Paid Partner Content
PPI Doubles Month Over Month to 1.0%
Apr 09 / Zacks.com - Paid Partner Content
Sage (SAGE), Biogen Report Positive Data on Essential Tremor Study
Apr 13 / Zacks.com - Paid Partner Content
Lilly's (LLY) JAK Inhibitor Olumiant Fails COVID-19 Study
Apr 09 / Zacks.com - Paid Partner Content
Myovant (MYOV), Pfizer Start Dosing in Relugolix Combo Study
Apr 13 / Zacks.com - Paid Partner Content
This Is Why Moderna Is a Great Stock to Buy Right Now
Apr 09 / MotleyFool.com - Paid Partner Content
Why Bad COVID-19 News Didn't Stop the Nasdaq From Rising Tuesday
Apr 13 / MotleyFool.com - Paid Partner Content
3 Robinhood Stocks That Are Ridiculously Cheap
Apr 09 / MotleyFool.com - Paid Partner Content
The Johnson & Johnson COVID Vaccine Halt: Here's What Investors Need to Know
Apr 13 / MotleyFool.com - Paid Partner Content
Top COVID-19 Vaccine Stories of March Put Biotech ETFs in Focus
Apr 08 / Zacks.com - Paid Partner Content
Consumer Price Index Rise 0.6%
Apr 13 / Zacks.com - Paid Partner Content
John W. Brooker & Co., CPAs Buys Schwab US Dividend Equity ETF, iShares Core Growth ...
Apr 08 / GuruFocus News - Paid Partner Content
CPI +0.6%: Higher, but Not Scary; JNJ Vax on Hold?
Apr 13 / Zacks.com - Paid Partner Content
AstraZeneca (AZN) COVID-19 Jab May Have Link to Rare Blood Clots
Apr 08 / Zacks.com - Paid Partner Content
These 6 Words From Moderna's CMO May Mean Billions in 2022
Apr 13 / MotleyFool.com - Paid Partner Content
How AstraZeneca's latest vaccine troubles could slow the global recovery
Apr 08 / CNN.com - Paid Partner Content
A Surprising Vaccine Rival May Upset the Dreams of Anyone Holding Moderna and Pfizer Stock
Apr 13 / MotleyFool.com - Paid Partner Content
Neumann Advisory Hong Kong Ltd Buys XPeng Inc, Moderna Inc, Sells Alibaba Group Holding
Apr 08 / GuruFocus News - Paid Partner Content
Here's the Biggest Challenge Pfizer Faces Right Now
Apr 13 / MotleyFool.com - Paid Partner Content
Is It Time to Buy the Nasdaq's Biggest Dippers?
Apr 07 / MotleyFool.com - Paid Partner Content
Will Worse Side Effects for Moderna's Vaccine Boost Pfizer's Fortunes?
Apr 13 / MotleyFool.com - Paid Partner Content
Earnings Estimates Rising for Moderna (MRNA): Will It Gain?
Apr 07 / Zacks.com - Paid Partner Content